
Sign up to save your podcasts
Or


AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.
By The Motley Fool4.7
16041,604 ratings
AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.

3,221 Listeners

1,491 Listeners

806 Listeners

947 Listeners

525 Listeners

1,166 Listeners

2,180 Listeners

825 Listeners

1,423 Listeners

1,035 Listeners

9,716 Listeners

197 Listeners

827 Listeners

85 Listeners

591 Listeners

1,025 Listeners

53 Listeners